BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29999200)

  • 1. Recent Progress on Manganese-Based Nanostructures as Responsive MRI Contrast Agents.
    García-Hevia L; Bañobre-López M; Gallo J
    Chemistry; 2019 Jan; 25(2):431-441. PubMed ID: 29999200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T
    Addisu KD; Hailemeskel BZ; Mekuria SL; Andrgie AT; Lin YC; Tsai HC
    ACS Appl Mater Interfaces; 2018 Feb; 10(6):5147-5160. PubMed ID: 29277987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Nanomaterials as Contrast Agents for MRI.
    Caspani S; Magalhães R; Araújo JP; Sousa CT
    Materials (Basel); 2020 Jun; 13(11):. PubMed ID: 32517085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese-Based Nanogels as pH Switches for Magnetic Resonance Imaging.
    Caro C; García-Martín ML; Pernia Leal M
    Biomacromolecules; 2017 May; 18(5):1617-1623. PubMed ID: 28368576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
    Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
    Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tunable Performance of Manganese Oxide Nanostructures as MRI Contrast Agents.
    Bañobre-López M; García-Hevia L; Cerqueira MF; Rivadulla F; Gallo J
    Chemistry; 2018 Jan; 24(6):1295-1303. PubMed ID: 29178467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-Nanomaterial Interaction to Escalate Twin-Mode Magnetic Resonance Imaging.
    Haribabu V; Girigoswami K; Sharmiladevi P; Girigoswami A
    ACS Biomater Sci Eng; 2020 Aug; 6(8):4377-4389. PubMed ID: 33455176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Nanotheranostic Agents for Tumor Microenvironment-Responsive Magnetic Resonance Imaging.
    Jin L; Yang C; Wang J; Li J; Xu N
    Front Pharmacol; 2022; 13():924131. PubMed ID: 35814250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
    Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
    Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fe/Mn Multilayer Nanowires as High-Performance T
    Cao X; Gu L; Hu S; Mukhtar A; Wu K
    Materials (Basel); 2021 Apr; 14(9):. PubMed ID: 33925382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nano-theranostics and Nitroxyl Radical-labeled Antitumor Agents for Magnetic Resonance Imaging].
    Aoki I
    Yakugaku Zasshi; 2016; 136(8):1087-91. PubMed ID: 27477722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile synthesis of manganese silicate nanoparticles for pH/GSH-responsive T
    Li XW; Zhao WR; Liu YJ; Liu XH; Shi P; Li YS; Shi JL
    J Mater Chem B; 2016 Jun; 4(24):4313-4321. PubMed ID: 32263413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
    Huang CC; Khu NH; Yeh CS
    Biomaterials; 2010 May; 31(14):4073-8. PubMed ID: 20149451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese-enhanced magnetic resonance imaging in experimental spinal cord injury: correlation between T1-weighted changes and Mn(2+) concentrations.
    Martirosyan NL; Bennett KM; Theodore N; Preul MC
    Neurosurgery; 2010 Jan; 66(1):131-6. PubMed ID: 20023543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring dynamic alterations in calcium homeostasis by T1-mapping manganese-enhanced MRI (MEMRI) in the early stage of small intestinal ischemia-reperfusion injury.
    Zhao DW; Zhang LT; Cheng HY; Zhang YL; Min JY; Xiao HL; Wang Y
    NMR Biomed; 2015 Aug; 28(8):958-66. PubMed ID: 26086648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis.
    Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain.
    Brunnquell CL; Hernandez R; Graves SA; Smit-Oistad I; Nickles RJ; Cai W; Meyerand ME; Suzuki M
    Contrast Media Mol Imaging; 2016 Sep; 11(5):371-380. PubMed ID: 27396476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
    Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
    Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
    Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
    Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary strategies for developing Gd-free high-field T₁ MRI contrast agents based on Mn(III) porphyrins.
    Cheng W; Haedicke IE; Nofiele J; Martinez F; Beera K; Scholl TJ; Cheng HL; Zhang XA
    J Med Chem; 2014 Jan; 57(2):516-20. PubMed ID: 24328058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.